Tenet Healthcare (NYSE:THC) Price Target Raised to $270.00 at Truist Financial

Tenet Healthcare (NYSE:THC) had its price objective upped by investment analysts at Truist Financial from $240.00 to $270.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s target price indicates a potential upside of 16.04% from the stock’s current price.

A number of other equities analysts have also recently weighed in on the company. TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a report on Thursday. Raymond James Financial set a $245.00 target price on shares of Tenet Healthcare in a report on Wednesday, October 29th. JPMorgan Chase & Co. lifted their price target on shares of Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Barclays raised their target price on shares of Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $260.00 price target on shares of Tenet Healthcare in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus price target of $246.71.

Tenet Healthcare Price Performance

Shares of NYSE:THC traded up $1.58 during trading on Tuesday, hitting $232.68. 253,196 shares of the stock were exchanged, compared to its average volume of 1,050,829. The company has a market cap of $20.45 billion, a PE ratio of 15.02, a P/E/G ratio of 0.96 and a beta of 1.45. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $235.77. The company has a fifty day moving average price of $199.32 and a two-hundred day moving average price of $195.68. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. During the same quarter in the previous year, the business posted $3.44 earnings per share. The firm’s quarterly revenue was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts forecast that Tenet Healthcare will post 12.24 EPS for the current year.

Insiders Place Their Bets

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.81% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC grew its stake in shares of Tenet Healthcare by 6.1% in the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after buying an additional 166 shares in the last quarter. Jones Financial Companies Lllp grew its position in Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after acquiring an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC purchased a new stake in shares of Tenet Healthcare during the second quarter valued at approximately $290,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Tenet Healthcare in the second quarter valued at $2,512,000. Finally, Chicago Partners Investment Group LLC purchased a new stake in Tenet Healthcare during the 2nd quarter worth $273,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.